Pembrolizumab-induced vasculitis demonstrated by FDG-PET/CT

Pembrolizumab-induced vasculitis demonstrated by FDG-PET/CT

A 76-year-old man with a history of malignant pleural mesothelioma treated with pembrolizumab underwent FDG-PET/CT for restaging. The images demonstrated FDG uptake overlying the right hepatic and splenic artery, which were new from the previous FDG-PET/CT 2.5 years prior before the patient started...

Full description

Bibliographic Details
Main Authors: Tuan Vu, BS, Sophia R. O'Brien, MD, Shawn X. Ma, MD, Karthik M. Sundaram, MD, PhD, Austin R. Pantel, MD, MSTR
Format: Article
Language:English
Published: Elsevier 2024-09-01
Series:Radiology Case Reports
Subjects:
PET imaging
FDG
Vasculitis
Pembrolizumab
Immune checkpoint inhibitors
Online Access:http://www.sciencedirect.com/science/article/pii/S1930043324005235

Internet

http://www.sciencedirect.com/science/article/pii/S1930043324005235

Similar Items